Literature DB >> 34339501

Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR-T cell therapy.

Binod Dhakal1, Sameem M Abedin1, Timothy S Fenske1, Saurabh Chhabra1, Nathan Ledeboer1, Parameswaran Hari1, Mehdi Hamadani1.   

Abstract

Entities:  

Year:  2021        PMID： 34339501      PMCID： PMC8332674          DOI： 10.1182/blood.2021012769

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  34 in total

1.  Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy.

Authors:  David J Chung; Gunjan L Shah; Roni Tamari; Ioannis Politikos; David A Knorr; Santosha A Vardhana; Jennifer C Young; LeeAnn T Marcello; Sital Doddi; Sean M Devlin; Lakshmi V Ramanathan; Melissa S Pessin; Erica Dunn; Meighan Palazzo; Christina D Bravo; Genovefa A Papanicolaou; Mini Kamboj; Miguel Angel Perales
Journal:  Blood Cancer Discov       Date:  2021-09-13

2.  Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients.

Authors:  Laura Thümmler; Michael Koldehoff; Neslinur Fisenkci; Leonie Brochhagen; Peter A Horn; Adalbert Krawczyk; Monika Lindemann
Journal:  Vaccines (Basel)       Date:  2022-06-18

Review 3.  A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies.

Authors:  Maryam Noori; Shadi Azizi; Farhan Abbasi Varaki; Seyed Aria Nejadghaderi; Davood Bashash
Journal:  Int Immunopharmacol       Date:  2022-07-12       Impact factor: 5.714

Review 4.  Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy.

Authors:  Kitsada Wudhikarn; Miguel-Angel Perales
Journal:  Bone Marrow Transplant       Date:  2022-07-15       Impact factor: 5.174

5.  Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell-treated patients.

Authors:  Bernice Ling Zhi Oh; Nicole Tan; Ruklanthi de Alwis; Kamini Kunasegaran; Zhiwei Chen; Michelle Poon; Esther Chan; Jenny G H Low; Allen Eng Juh Yeoh; Antonio Bertoletti; Nina Le Bert
Journal:  Blood       Date:  2022-07-14       Impact factor: 25.476

6.  Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients.

Authors:  Xi Wu; Lu Wang; Lu Shen; Lin He; Kefu Tang
Journal:  J Hematol Oncol       Date:  2022-06-16       Impact factor: 23.168

7.  How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies.

Authors:  Firas El Chaer; Jeffery J Auletta; Roy F Chemaly
Journal:  Blood       Date:  2022-08-18       Impact factor: 25.476

Review 8.  Vaccination for SARS-CoV-2 in Hematological Patients.

Authors:  Niccolò Riccardi; Marco Falcone; Dafna Yahav
Journal:  Acta Haematol       Date:  2022-02-25       Impact factor: 3.068

9.  SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders.

Authors:  José Luis Piñana; Lucia López-Corral; Rodrigo Martino; Lourdes Vazquez; Ariadna Pérez; Gabriel Martin-Martin; Beatriz Gago; Gabriela Sanz-Linares; Andrés Sanchez-Salinas; Lucia Villalon; Venancio Conesa-Garcia; María T Olave; Magdalena Corona; Sara Marcos-Corrales; Mar Tormo; José Ángel Hernández-Rivas; Juan Montoro; Alicia Rodriguez-Fernandez; Irene Risco-Gálvez; Pablo Rodríguez-Belenguer; Juan Carlos Hernandez-Boluda; Irene García-Cadenas; Montserrat Ruiz-García; Juan Luis Muñoz-Bellido; Carlos Solano; Ángel Cedillo; Anna Sureda; David Navarro
Journal:  J Hematol Oncol       Date:  2022-05-07       Impact factor: 23.168

10.  SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine.

Authors:  Béatrice Clémenceau; Thierry Guillaume; Marianne Coste-Burel; Pierre Peterlin; Alice Garnier; Amandine Le Bourgeois; Maxime Jullien; Jocelyn Ollier; Audrey Grain; Marie C Béné; Henri Vié; Patrice Chevallier
Journal:  Vaccines (Basel)       Date:  2022-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.